5 Best Performing Biotech Stocks in 2023

2. MoonLake Immunotherapeutics (NASDAQ:MLTX)

Year To Date Share Price Gains: 408.16%

MoonLake Immunotherapeutics (NASDAQ:MLTX) is developing an immune system disorder drug, and seeking to target diseases such as arthritis and other diseases. The firm’s treatment for a skin disease saw 57% of the patients in the trial showing some levels of improvement according to data shared in October 2023.

Insider Monkey’s June quarter of 2023 survey covering 910 hedge funds revealed that 29 were MoonLake Immunotherapeutics (NASDAQ:MLTX)’s investors.

Follow Moonlake Immunotherapeutics